Dr Reddys Labs has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the formulations manufacturing facility in Srikakulam, Andhra Pradesh.
USFDA had conducted an inspection on 7th July 2022 at formulations manufacturing facility (FTO 11) in Srikakulam, Andhra Pradesh.
- Read more about Dr Reddys Labs receives EIR from USFDA for Srikakulam based facility
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2022/dr-reddys-labs-receives-eir-from-usfda-for-srikakulam-based-facility
No comments:
Post a Comment